Search

everythinglearnresearchcommunity

for

Search:↓

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Weight-loss drugs are not linked to suicidal thoughts.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Treating Netherton syndrome with growth hormone and dupilumab improves growth safely.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.